Literature DB >> 4187575

Prevention of rapid immune elimination of anti-lymphocytic globulin in transplant patients.

W T Butler, R D Rossen, E M Hersh, M E DeBakey, E B Diethrich, D K Brooks, D A Cooley, J J Nora, R D Leachman, D G Rochelle, J J Trentin, K P Judd, A C Beall, D E Jenkins, R O Morgen, V Knight.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4187575     DOI： 10.1038/224856a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  4 in total

1.  The immunogenic components of equine anti-human lymphocyte lobulin in renal allograft recipients.

Authors:  R E Wolf; A R Remmers; H E Sarles; J C Fish; J D Lindley; T M Vyvial; S E Ritzmann
Journal:  Clin Exp Immunol       Date:  1972-02       Impact factor: 4.330

2.  Antilymphocytic serum--the possible clinical applications.

Authors:  M H Lessof
Journal:  Proc R Soc Med       Date:  1970-09

3.  The intravenous administration of equine antilymphocytic globulin in renal transplant recipients and the detection of circulating antibodies to equine globulin.

Authors:  K James; D M Pullar; J B Morton; R G Dalton; B Nolan; M F Woodruff
Journal:  Clin Exp Immunol       Date:  1971-04       Impact factor: 4.330

4.  Immunologic responses of graft recipients to antilymphocyte globulin: effect of prior treatment with aggregate-free gamma globulin.

Authors:  M E Weksler; G Bull; G H Schwartz; K H Stenzel; A L Rubin
Journal:  J Clin Invest       Date:  1970-08       Impact factor: 14.808
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.